Commercial Simplex and Multiplex PCR Assays for the Detection of Intestinal Parasites , spp., and spp.: Comparative Evaluation of Seven Commercial PCR Kits with Routine In-House Simplex PCR Assays.

Fiche publication

Date publication

novembre 2021

Journal

Microorganisms

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNIN Alain

Tous les auteurs :
Basmaciyan L, François A, Vincent A, Valot S, Bonnin A, Costa D, Razakandrainibe R, Morio F, Favennec L, Dalle F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34835453

Résumé

Nowadays, many commercial kits allowing the detection of digestive parasites by DNA amplification methods have been developed, including simplex PCR assays (SimpPCRa) allowing the identification of a single parasite, and multiplex PCR assays (MultPCRa) allowing the identification of several parasites at once. Thus, aimed at improving the diagnosis of intestinal protozoal infections, it is essential to evaluate the performances of these new tools. A total of 174 DNA samples collected between 2007 and 2017 were retrospectively included in this study. Performances of four commercial SimpPCRa (i.e., CerTest-VIASURE) and three MultPCRa (i.e., CerTest-VIASURE, FAST-TRACK-Diagnostics-FTD-Stool-Parasite and DIAGENODE-Gastroenteritis/Parasite-panel-I) were evaluated for the detection of spp., spp., and in stool samples compared to our routinely used in-house SimpPCRa. Globally, the SimpPCRa showed better sensitivity/specificity for the detection of , , and spp. (i.e., 96.9/93.6%; 100/100%; 95.5/100%; and 100/99.3%, respectively), compared to the three commercial MultPCRa tested. All in all, we showed that MultPCRa offer an interesting alternative for the detection of protozoans in stool samples depending on the clinical context.